• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVH

AVITA MEDICAL INC. - Announcements

0.46% ! $2.20
Market Cap $67.72M  !

Avita Medical Limited is a regenerative medicine company with a technology platform to... Avita Medical Limited is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The Company’s technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. Its product, the RECELL System for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. The RECELL System is designed to be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



AVH Release of Securities from Voluntary Escrow18/04/18
AVH RECELL Successful Pivotal Trial Data Presented at ABA Day 3PRICE SENSITIVE16/04/18
AVH RECELL Excellent Cosmetic Outcomes presented at ABA Day 2PRICE SENSITIVE13/04/18
AVH RECELL data presented during Day 1 of ABA Annual MeetingPRICE SENSITIVE12/04/18
AVH Schedule for Six RECELL Presentations at ABA Conference03/04/18
AVH RECELL Health Economic Model to be Presented at ISPOR26/03/18
AVH Change in substantial holding22/03/18
AVH US Burn Surgeon to Discuss Groundbreaking Use of RECELL22/03/18
AVH AVITA Medical Corporate Presentation20/03/18
AVH AVITA to Present at Oppenheimer Healthcare Conference in NYC20/03/18
AVH Change of Company Secretary and Change in Registered Address19/03/18
AVH Clinical Trial of RECELL in China funded by GovernmentPRICE SENSITIVE19/03/18
AVH Half Yearly Report and AccountsPRICE SENSITIVE28/02/18
AVH FDA Approves Expansion of RECELL Compassionate Use ProgramPRICE SENSITIVE12/02/18
AVH Release of Securities from Voluntary Escrow
18/04/18
AVH RECELL Successful Pivotal Trial Data Presented at ABA Day 3
16/04/18PRICE SENSITIVE
AVH RECELL Excellent Cosmetic Outcomes presented at ABA Day 2
13/04/18PRICE SENSITIVE
AVH RECELL data presented during Day 1 of ABA Annual Meeting
12/04/18PRICE SENSITIVE
AVH Schedule for Six RECELL Presentations at ABA Conference
03/04/18
AVH RECELL Health Economic Model to be Presented at ISPOR
26/03/18
AVH Change in substantial holding
22/03/18
AVH US Burn Surgeon to Discuss Groundbreaking Use of RECELL
22/03/18
AVH AVITA Medical Corporate Presentation
20/03/18
AVH AVITA to Present at Oppenheimer Healthcare Conference in NYC
20/03/18
AVH Change of Company Secretary and Change in Registered Address
19/03/18
AVH Clinical Trial of RECELL in China funded by Government
19/03/18PRICE SENSITIVE
AVH Half Yearly Report and Accounts
28/02/18PRICE SENSITIVE
AVH FDA Approves Expansion of RECELL Compassionate Use Program
12/02/18PRICE SENSITIVE
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
$2.20
Change
0.010(0.46%)
Mkt cap ! $67.72M
Open High Low Volume
$2.22 $2.22 $2.20 47.09K

Buyers (Bids)

Vol. Price($)
896 $2.20
 

Sellers (Offers)

Price($) Vol.
$2.21 26322
Last trade - 11.48am 18/08/2026 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.